EC Number   |
Activating Compound |
Reference |
|---|
   3.1.1.47 | lipopolysaccharides |
regulatory function on the enzyme form from plasma, liver, spleen, lung, and small intestine |
650326 |
| 3.1.1.47 | M-CSF |
regulatory function on the enzyme form from monocyte-derived macrophages |
650326 |
| 3.1.1.47 | more |
3fold increase in activity in subjects with meningitis |
649522 |
| 3.1.1.47 | more |
dose-dependent induction of enzyme expression by pioglitazone |
667771 |
| 3.1.1.47 | more |
membrane binding of HpPAF-AH increases the activity of enzyme, by interfacial activation. The lipid composition of membrane vesicles, by changing the physicochemical properties, differentially modulates the binding, partial membrane penetration and the activity of the enzyme, detailed overview |
714337 |
| 3.1.1.47 | more |
the enzyme is associated with low-density lipoprotein LDL and high-density lipoprotein HDL particles |
652705 |
| 3.1.1.47 | platelet-activating factor |
regulatory function on the enzyme form from hepatocytes |
650326 |
| 3.1.1.47 | platelet-activating factor |
regulatory function on the enzyme form from HepG2 cells and monocyte-derived macrophages, no effect on erythrocytes and erythrocyte isozyme |
650326 |
| 3.1.1.47 | progestin |
regulatory function on the enzyme form from HL-60 cells |
650326 |
| 3.1.1.47 | progestin |
regulatory function on the enzyme form from plasma |
650326 |
